Cargando…

Berberine Inhibits Cell Proliferation by Interfering with Wild-Type and Mutant P53 in Human Glioma Cells

INTRODUCTION: Glioma is the most common malignant brain tumor. TP53 is the most common mutant gene in human cancer. Wild-type p53 (wtp53) is a tumor suppressor protein whereas mutant p53 (mutp53) is an oncoprotein that promotes tumor cell proliferation. Our aim was to examine the inhibitory effects...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ziqiang, Chen, Yong, Gao, Haijun, Xu, Weidong, Zhang, Chaochao, Lai, Jiacheng, Liu, Xingxing, Sun, Yuxue, Huang, Haiyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699991/ https://www.ncbi.nlm.nih.gov/pubmed/33262612 http://dx.doi.org/10.2147/OTT.S279002

Ejemplares similares

Pterostilbene promotes mitochondrial apoptosis and inhibits proliferation in glioma cells
por: Gao, Haijun, et al.
Publicado: (2021)

Mechanisms involved in the anti-tumor effects of Toosendanin in glioma cells
por: Zhang, Chaochao, et al.
Publicado: (2021)

Anticancer effects of OSW-1 on glioma cells via regulation of the PI3K/AKT signal pathway: A network pharmacology approach and experimental validation in vitro and in vivo
por: Zhan, Zhixin, et al.
Publicado: (2022)

APR-246—The Mutant TP53 Reactivator—Increases the Effectiveness of Berberine and Modified Berberines to Inhibit the Proliferation of Pancreatic Cancer Cells
por: McCubrey, James Andrew, et al.
Publicado: (2022)

Interfering with hyaluronic acid metabolism suppresses glioma cell proliferation by regulating autophagy
por: Yan, Tao, et al.
Publicado: (2021)

Interfering with CALCRL expression inhibits glioma proliferation, promotes apoptosis, and predicts prognosis in low-grade gliomas
por: Gu, Shengcai, et al.
Publicado: (2022)

Anticancer Effects and Mechanisms of OSW-1 Isolated From Ornithogalum saundersiae: A Review
por: Zhan, Zhixin, et al.
Publicado: (2021)

HS-1793 inhibits cell proliferation in lung cancer by interfering with the interaction between p53 and MDM2
por: Lim, Chungun, et al.
Publicado: (2022)

The inhibiting effect of neural stem cells on proliferation and invasion of glioma cells
por: An, Jing, et al.
Publicado: (2017)

TP53 wild-type/PPM1D mutant diffuse intrinsic pontine gliomas are sensitive to a MDM2 antagonist
por: Xu, Cheng, et al.
Publicado: (2021)

Mutant p53 accumulates in cycling and proliferating cells in the normal tissues of p53 R172H mutant mice
por: Goh, Amanda M., et al.
Publicado: (2015)

A Mutant Isoform of ObgE Causes Cell Death by Interfering with Cell Division
por: Dewachter, Liselot, et al.
Publicado: (2017)

The Inhibition of Autophagy Sensitises Colon Cancer Cells with Wild-Type p53 but Not Mutant p53 to Topotecan Treatment
por: Li, Dan-Dan, et al.
Publicado: (2012)

CITED2 affects leukemic cell survival by interfering with p53 activation
por: Mattes, Katharina, et al.
Publicado: (2017)

Kevetrin induces apoptosis in TP53 wild-type and mutant acute myeloid leukemia cells
por: Napolitano, Roberta, et al.
Publicado: (2020)

Alternative splicing of human telomerase reverse transcriptase in gliomas and its modulation mediated by CX-5461
por: Li, Guihong, et al.
Publicado: (2018)

Editorial: Advances in wild type and mutant p53 research in cancer
por: Hernández-de la Cruz, Olga N., et al.
Publicado: (2022)

Wild-type and mutant p53 differentially modulate miR-124/iASPP feedback following pohotodynamic therapy in human colon cancer cell line
por: Liu, Kuijie, et al.
Publicado: (2017)

Differential Angiogenic Gene Expression in TP53 Wild-Type and Mutant Ovarian Cancer Cell Lines
por: Davidson, Brittany Anne, et al.
Publicado: (2014)

Differential regulated microRNA by wild type and mutant p53 in induced pluripotent stem cells
por: Grespi, Francesca, et al.
Publicado: (2016)

Mitochondria play an important role in the cell proliferation suppressing activity of berberine
por: Yan, Xiao-Jin, et al.
Publicado: (2017)

Berberine Could Ameliorate Cardiac Dysfunction via Interfering Myocardial Lipidomic Profiles in the Rat Model of Diabetic Cardiomyopathy
por: Dong, Shifen, et al.
Publicado: (2018)

Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide
por: Lin, Tseng-Hsi, et al.
Publicado: (2008)

Mutant p53 Cooperates with Knockdown of Endogenous Wild-Type p53 to Disrupt Tubulogenesis in Madin-Darby Canine Kidney Cells
por: Zhang, Yanhong, et al.
Publicado: (2013)

Trans-splicing repair of mutant p53 suppresses the growth of hepatocellular carcinoma cells in vitro and in vivo
por: He, Xingxing, et al.
Publicado: (2015)

Dysregulated Dermal Mesenchymal Stem Cell Proliferation and Differentiation Interfered by Glucose Metabolism in Psoriasis
por: Zhao, Xincheng, et al.
Publicado: (2021)

Mutant p53 in cell-cell interactions
por: Pilley, Steven, et al.
Publicado: (2021)

PCSK9 promotes tumor cell proliferation and migration by facilitating CCL25 secretion in esophageal squamous cell carcinoma
por: Wang, Haijun, et al.
Publicado: (2023)

Survivin-specific small interfering RNAs enhance sensitivity of glioma U-87MG cells to paclitaxel by promoting apoptosis☆
por: Xie, Yunliang, et al.
Publicado: (2012)

Small Interfering RNA for Gliomas Treatment: Overcoming Hurdles in Delivery
por: Teng, Xin-Qi, et al.
Publicado: (2022)

Glucose-coated Berberine Nanodrug for Glioma Therapy through Mitochondrial Pathway
por: Wang, Shubin, et al.
Publicado: (2020)

AQP3 small interfering RNA and PLD2 small interfering RNA inhibit the proliferation and promote the apoptosis of squamous cell carcinoma
por: Wang, Xiaoyong, et al.
Publicado: (2017)

Noncanonical DNA Motifs as Transactivation Targets by Wild Type and Mutant p53
por: Jordan, Jennifer J., et al.
Publicado: (2008)

Maspin subcellular expression in wild-type and mutant TP53 gastric cancers
por: Gurzu, Simona, et al.
Publicado: (2020)

Advanced Strategies for Therapeutic Targeting of Wild-Type and Mutant p53 in Cancer
por: Zhang, Shengliang, et al.
Publicado: (2022)

Interfering with pak4 Protein Expression Affects Osteosarcoma Cell Proliferation and Migration
por: Fu, Yuxin, et al.
Publicado: (2021)

Schedule-dependent cytotoxicity of SN-38 in p53 wild-type and mutant colon adenocarcinoma cell lines
por: Poele, R H te, et al.
Publicado: (1999)

Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53
por: Lu, Phong, et al.
Publicado: (2019)

Anticancer efficacy of hirsuteine against colorectal cancer by opposite modulation of wild-type and mutant p53
por: Zhang, Yan, et al.
Publicado: (2023)

Update on Berberine in Nonalcoholic Fatty Liver Disease
por: Liu, Yang, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_slli8hr7hu8tfk7dc4erh5a8o4